Shreyaansh Lifesciences, Jaipur. India

erdafitinib tablets
Erdafitinib is a kinase inhibitor indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma that has susceptible FGFR3 or FGFR2 genetic alterations and progressed during or following at least one line of prior platinum containing chemotherapy including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy.

Get Access To erdafitinib tablets

Ribociclib-tablets Available Price In India UK Saudi Arabia

Erdafitinib tablets

  • API – erdafitinib tablets, for oral use
  • Packaging – Tablets
  • Strength – 3 mg, 4 mg, and 5 mg. tablets 
  • Manufacturer Name – Janssen Products, LP

What is erdafitinib used for?

Erdafitinib is an anti-cancer medication. It is a small molecule inhibitor of fibroblast growth factor receptor (FGFR) used for the treatment of cancer. FGFRs are a subset of tyrosine kinases which are unregulated in some tumors and influence tumor cell differentiation, proliferation, angiogenesis, and cell survival.

In March 2018, erdafitinib was granted breakthrough therapy designation by the U.S. Food and Drug Administration (FDA) for treatment of urothelial cancer.In April 2019, erdafitinib was granted approval by the FDA for treatment of metastatic or locally advanced bladder cancer.

    Disclaimer

    All Trademarks and Brands that appear on website belong to their respective owners does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Iron Sucrose is a pharmaceutical drug that legally requires a medical prescription to be dispensed. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.